Search

everythinglearnresearchcommunity

for

Search:↓

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

A guinea pig with ovarian cysts had a uterine infection and abnormal uterus lining due to a piece of hay inside it.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

A 15-year-old girl with missed periods was diagnosed with a pituitary disorder and treated with hormones and steroids.

Early diagnosis and treatment with Leuprolide are key for children with precocious puberty.

A woman got a serious strep infection from an IUD, likely passed from her husband's infected throat during sexual activity.

Two women experienced temporary hair loss and other side effects from imiquimod treatment for cervical issues, which stopped after ending the treatment.

A 24-month-old Nigerian girl developed early puberty with no family history, needing treatment her family couldn't afford.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Recurrent vaginal bleeding in young girls without puberty signs may require a genital exam to find hidden causes.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Netherton syndrome can cause severe and chronic vulvovaginal symptoms that may improve with continuous oral contraceptives.

The document says that hookworms are treated with mebendazole and stress-related hair loss usually gets better in 6 months, while other hair loss types have specific treatments.

A 1-day or 3-day itraconazole treatment is effective for acute vulvovaginal candidosis, but recurrent cases may need longer treatment.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Ayurvedic treatment helped a woman with PCOS conceive and deliver a healthy baby.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Toxic Shock Syndrome mainly affects menstruating women, can recur, and is linked to staph bacteria, with rapid treatment being crucial.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Menopause can cause skin issues, and seeing a dermatologist helps.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.